Taiyen Biotech Co

Taiyen Biotech Co EBIT

The EBIT of Taiyen Biotech Co (1737.TW) as of Nov 4, 2026 is 474.19 M TWD. In the previous year, EBIT was 437.15 M TWD — a change of 8.47% (higher).

EBIT

474.19 MTWD

YoY

8.47%

Last updated:

In 2025, Taiyen Biotech Co's EBIT was 474.19 M TWD, a 8.47% increase from the 437.15 M TWD EBIT recorded in the previous year.

The Taiyen Biotech Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
418.51 M TWD
Jan 1, 2019
430.94 M TWD
Jan 1, 2020
467.64 M TWD
Jan 1, 2021
515.86 M TWD
Jan 1, 2022
535.11 M TWD
Jan 1, 2023
316.01 M TWD
Jan 1, 2024
437.15 M TWD
Jan 1, 2025
474.19 M TWD
The Taiyen Biotech Co EBIT history
YEAREBITYoY
474.19 MTWD+8.47%
437.15 MTWD+38.34%
316.01 MTWD-40.95%
535.11 MTWD+3.73%
515.86 MTWD+10.31%
467.64 MTWD+8.52%
430.94 MTWD+2.97%
418.51 MTWD+0.10%
418.09 MTWD+2.02%
409.83 MTWD+32.50%
309.30 MTWD+87.49%
164.96 MTWD+66.14%
99.29 MTWD+107.12%
47.94 MTWD-79.16%
230.07 MTWD+0.30%
229.37 MTWD+1.42%
226.17 MTWD-5.04%
238.17 MTWD+76.11%
135.24 MTWD-48.79%
264.07 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Taiyen Biotech Co Revenue

Taiyen Biotech Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
3.00 B TWD
418.51 M TWD
452.74 M TWD
Jan 1, 2019
2.91 B TWD
430.94 M TWD
345.50 M TWD
Jan 1, 2020
3.13 B TWD
467.64 M TWD
365.09 M TWD
Jan 1, 2021
4.10 B TWD
515.86 M TWD
393.23 M TWD
Jan 1, 2022
3.61 B TWD
535.11 M TWD
426.70 M TWD
Jan 1, 2023
3.41 B TWD
316.01 M TWD
300.39 M TWD
Jan 1, 2024
3.24 B TWD
437.15 M TWD
371.52 M TWD
Jan 1, 2025
3.31 B TWD
474.19 M TWD
399.87 M TWD

Taiyen Biotech Co Margins

Taiyen Biotech Co stock margins

The Taiyen Biotech Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Taiyen Biotech Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Taiyen Biotech Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
40.02 %
13.94 %
15.08 %
Jan 1, 2019
41.64 %
14.83 %
11.89 %
Jan 1, 2020
41.77 %
14.94 %
11.66 %
Jan 1, 2021
33.53 %
12.60 %
9.60 %
Jan 1, 2022
35.33 %
14.81 %
11.81 %
Jan 1, 2023
35.49 %
9.27 %
8.81 %
Jan 1, 2024
40.79 %
13.50 %
11.47 %
Jan 1, 2025
40.60 %
14.34 %
12.09 %

Taiyen Biotech Co Stock analysis

What does Taiyen Biotech Co do? Taiyen Biotech Co Ltd is a Taiwanese company specializing in the development of food ingredients and biologically active substances. It was founded in 2002 by Dr. Yau-Lin Tseng, a renowned food chemist. Since its founding, Taiyen Biotech has developed and launched a wide range of products and services. The company focuses on the production of dietary supplements and functional foods that are intended to improve health and well-being. The business strategy of Taiyen Biotech is to produce innovative and scientifically supported products that meet the needs of customers. The company relies on intensive research and development to constantly improve its products and explore new markets. It collaborates closely with other industry, science, and technology partners. One of the most well-known divisions of Taiyen Biotech is the production of fermented dietary supplements based on microorganisms. The company has developed a series of innovative products that contain high concentrations of live bacterial cultures and are targeted towards various health needs and issues. Some of Taiyen Biotech's most famous products include food additives like Lactobacillus acidophilus-Lafti®L10, probiotic bacteria that support the immune system and inhibit the growth of pathogenic bacteria. Another product is Hydroxytyrosol, an antioxidant derivative of acetic acid that is used to combat oxidative stress and prevent chronic diseases such as cancer and cardiovascular diseases. Taiyen Biotech also offers services in the field of biotechnology, including the development of fermentation processes, the production of plant and animal cell cultures, and the manufacturing of enzymes and bioactive compounds. The products of Taiyen Biotech are distributed in many countries worldwide, including the USA, Europe, Asia, and Australia. The company is ISO 22000 certified and has received international certificates and recognition for its products and services. Overall, Taiyen Biotech has experienced high growth in recent years and has become a significant player in the global market for food ingredients and biologically active compounds. The company aims to further strengthen its market presence in the coming years and develop innovative products that meet the needs of customers. Taiyen Biotech Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Taiyen Biotech Co's EBIT

Taiyen Biotech Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Taiyen Biotech Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Taiyen Biotech Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Taiyen Biotech Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Taiyen Biotech Co stock

EBIT of Taiyen Biotech Co is 474.19 M TWD in 2025.

EBIT of Taiyen Biotech Co changed from 437.15 M TWD to 474.19 M TWD, representing a 8.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Taiyen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Taiyen Biotech Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Taiyen Biotech Co

All Key Metrics — Taiyen Biotech Co